Feedback / Questions
envudeucitinib (ESK-001) - Alumis
https://www.globenewswire.com/news-release/2026/09/01/3354011/0/en/alumis-announces-topline-results-from-envudeucitinib-phase-2b-trial-in-systemic-lupus-erythematosus-sle.html
Sep 1, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next